Sequence Similarity Clusters for the Entities in PDB 1I8I

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 48211
95 % 2 2 36010 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 2 2 34363
70 % 2 2 30535
50 % 146 312 23
40 % 442 956 5
30 % 491 1085 7
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 47238
95 % 2 2 35330 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 2 2 33726
70 % 197 399 9
50 % 278 599 6
40 % 443 956 5
30 % 492 1085 7
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
15 5IMM 1 B Nanobody 9835
16 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
17 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
18 5NLU 1 A single domain llama antibody Nb36 9844
19 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
20 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
21 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
22 5IMK 1 B Nanobody 9835
23 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
24 4B50 1 A 2H10 LLAMA VHH 9844
25 2XT1 2 B CAMELID VHH 9 30538
26 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
27 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
28 5J1S 3 C VHH domain BS-2 30538
29 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
30 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
31 5L6Q 1 A, B H5AL 9606
32 5J1T 3 C VHH domain BS-2 30538
33 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
34 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
35 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
36 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
37 2X1O 1 A, B GELSOLIN NANOBODY 9844
38 4QGY 1 A, B nanobody n25, VH domain 9844
39 5C2B 1 H scFv 3B4 heavy chain 9606
40 5C2B 2 L 3B4 light chain 9606
41 5VNV 1 A Nb.b201 32630
42 5DXW 1 A PD-L1 nanobody 10090
43 3T0W 1 A, B immunoglobulin variable lambda domain 9606
44 4N9O 2 B Nanobody Nb484 Nb484 9844
45 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
46 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
47 3T0V 1 A immunoglobulin variable lambda domain 9606
48 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
49 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
50 1T2J 1 A M12-Variable Heavy domain 9606
51 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
52 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
53 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
54 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
55 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
56 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
57 1SQ2 2 N novel antigen receptor 7801
58 4KML 2 B Nanobody 9844
59 4Z9K 2 B VHH2(F5) antibody 30538
60 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
61 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
62 5LMW 1 A Nanobody 9844
63 5NM0 1 A, B, C, D Nb36 9844
64 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
65 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
66 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
67 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
68 4PPT 1 A Engineered single domain VHH antibody 9844
69 3R0M 1 A, B Llama VHH A12 9844
70 3ZKQ 2 D XA4813 9844
71 4I13 2 B Protein ca1697 (nanobody) 9844
72 5C2U 1 B Nanobody Nanobody 9838
73 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
74 1XFP 1 A heavy chain antibody VHH domain 9838
75 4POY 1 A VHH-metal 9844
76 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
77 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
78 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
79 5NLW 1 A nanobody Nb36 9844
80 3CDC 1 A, B Light Chain Amyloidogenic 9606
81 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
82 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
83 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
84 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
85 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
86 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
87 3G9A 2 B Minimizer 9838
88 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
89 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
90 2P43 2 B ANTIBODY CAB-RN05 9838
91 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
92 4KRN 1 A Nanobody/VHH domain EgA1 9844
93 4GFT 2 B Nanobody 9844
94 4TVS 2 a, b VHH Domain BS-1 30538
95 4W6Y 2 B Nanobody NbFedF9 9844
96 6EZW 1 B VHH antibody BCD090-M2 9844
97 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
98 1UAC 2 H Ig VH,anti-lysozyme 10090
99 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
100 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
101 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
102 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
103 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
104 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
105 5O02 2 C Nanobody (VHH) Nano-4 30538
106 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
107 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
108 4X7F 2 C, D Nano-25 Nanobody 30538
109 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
110 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
111 4LGR 2 B Camelid nanobody (VHH3) 30538
112 5J57 2 B VHH single chain antibody V5E1 30538
113 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
114 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
115 5OMM 2 C Nanobody (VHH) Nano-14 30538
116 5E03 1 A mouse CTLA-4 nanobody 10090
117 5LZ0 1 A, B PorM nanobody 9844
118 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
119 2XXC 1 B CAMELID VHH 9 30538
120 3QYC 1 A, B VH domain of IgG molecule 9606
121 5VAK 2 B Nb914 Nanobody 9844
122 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
123 2XXM 2 B CAMELID VHH 9 30538
124 5IR3 1 A Ig lambda chain V-VI region AR 9606
125 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
126 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
127 5JDS 1 B Nanobody 9835
128 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
129 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
130 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
131 5L8L 2 B New antigen receptor variable domain 168098
132 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
133 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
134 4AIZ 1 A, C, D V2-17 PROTEIN 9606
135 4AIZ 2 B V2-17 PROTEIN 9606
136 5L21 2 B VHH-C2 30538
137 5FWO 1 A NANOBODY 9844
138 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
139 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
140 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
141 4L1H 1 A Ig kappa chain V-I region Rei 9606
142 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
143 3B9V 1 A, B, C, D heavy chain variable domain 9606
144 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
145 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
146 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
147 5N88 1 A, H VH59 antibody 9606
148 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
149 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
150 3BD3 1 A, B catalytic antibody 10090
151 2OTU 1 A, C, E, G Fv light chain variable domain 10090
152 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
153 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
154 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
155 5L8J 2 B New antigen receptor variable domain 168098
156 1T6V 2 N, O novel antigen receptor 7801
157 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
158 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
159 4N1C 1 A, B immunoglobulin variable light chain domain 9606
160 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
161 4POU 2 B VHH Antibody 9844
162 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
163 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
164 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
165 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
166 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
167 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
168 2P42 2 B, D ANTIBODY CAB-RN05 9838
169 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
170 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
171 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
172 4QLR 1 A, B Llama nanobody n02 VH domain 9844
173 5J56 2 B VHH single chain antibody V1C7 30538
174 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
175 4NBX 2 B A20.1 VHH 9844
176 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
177 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
178 4HEP 2 G vHH17 domain 9844
179 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
180 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
181 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
182 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
183 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
184 5IML 2 B Nanobody 9835
185 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
186 3A6C 2 H IG VH, anti-lysozyme 10090
187 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
188 2DQD 2 H Ig VH,anti-lysozyme 10090
189 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
190 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
191 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
192 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
193 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
194 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
195 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
196 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
197 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
198 3A67 2 H IG VH, anti-lysozyme 10090
199 2APB 1 A T-cell receptor beta chain V 10116
200 2APX 1 A T cell receptor beta chain V 10116
201 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
202 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
203 1J1X 2 H Ig VH,anti-lysozyme 10090
204 5L8K 2 B New antigen receptor variable domain 168098
205 5M2J 2 D Anti-(ED-B) scFV 9606
206 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
207 2DQC 2 H Ig VH,anti-lysozyme 10090
208 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
209 1J1O 2 H Ig VH,anti-lysozyme 10090
210 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
211 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
212 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
213 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
214 4M62 2 H, I GEP2 FV heavy chain 9606
215 5IVO 1 A BC2-nanobody 30538
216 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
217 1J1P 2 H Ig VH,anti-lysozyme 10090
218 4NBZ 2 B, D A26.8 VHH 9844
219 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
220 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
221 5AYU 2 H Ig VH,anti-lysozyme 10090
222 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
223 3A6B 2 H IG VH, anti-lysozyme 10090
224 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
225 2DQJ 2 H Ig VH,anti-lysozyme 10090
226 5F21 2 B nanobody MU375 9844
227 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
228 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
229 2P44 2 B ANTIBODY CAB-RN05 9838
230 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
231 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
232 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
233 5TP3 1 A, B F-VHH-4 9844
234 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
235 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
236 2JJW 1 A SIGNAL REGULATORY PROTEIN GAMMA ISOFORM 4 N-TERMINAL ECTODOMAIN, RESIDUES 29-147 9606
237 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
238 4LHJ 2 B Camelid antibody 30538
239 4BEL 2 D, E XA4813 9844
240 5M7Q 1 A, B Nanobody NbD2 9838
241 5H8D 1 A VHH nanobody 9844
242 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
243 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
244 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
245 3DUR 2 B, D Ig-like protein 10090
246 2APF 1 A T cell receptor beta chain V 10116
247 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
248 2XV6 2 B, D CAMELID VHH 9 30538
249 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
250 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
251 4ZG1 1 A, B, C, D, E, F NB17 9844
252 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
253 4I1N 2 B Protein ca1697 (nanobody) 9844
254 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
255 2UV3 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 CD47 BINDING DOMAIN, RESIDUES 31-148 9606
256 5C9K 1 A, B, C, D, E, F, G, H Amyloid lambda 6 light chain variable region PIP 9606
257 6F0D 1 A, B VHH antibody BCD090-M2 9844
258 1FGV 1 L H52 FV (LIGHT CHAIN) 9606
259 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
260 4LCI 1 L anti canine CD28 antibody, 1C6, light chain 10090
261 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
262 1WAA 1 A, B, C, D TITIN IG DOMAIN, RESIDUES 12801-12889 9606 2.7.1 | Details
263 1WAA 2 E TITIN IG DOMAIN, RESIDUES 12801-12889 9606 2.7.1 | Details
264 1WAA 3 F TITIN IG DOMAIN, RESIDUES 12801-12889 9606 2.7.1 | Details
265 4W6X 2 B Nanobody NbFedF7 9844
266 5JA9 2 A, B Nanobody 6 9844
267 1A7N 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
268 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
269 1CD0 1 A, B PROTEIN (JTO, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) IMMUNOGLOBULIN VARIABLE DOMAIN 9606
270 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
271 1OP9 1 A HL6 camel VHH fragment 9838
272 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
273 4C4K 1 O OBSCURIN FIRST IG DOMAIN, RESIDUES 9-103 9606 2.7.11.1 | Details
274 4C4K 2 T TITIN M10 DOMAIN, RESIDUES 34252-34350 9606 2.7.11.1 | Details
275 4LRN 1 H GEP 1 heavy chain 9606
276 4LRN 2 L GEP 1 light chain 9606
277 4S11 1 A GELSOLIN NANOBODY 9844
278 1EK3 1 A, B KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL, REC 9606
279 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
280 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
281 2YC1 2 B, E SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN 9606
282 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
283 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
284 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
285 1G7H 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
286 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
287 2APV 1 A T cell receptor beta chain V 10116
288 4Y7M 1 A, B Hi113 protein 9844
289 5JMO 2 C, D camelid VHH fragment 9838
290 1A7O 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
291 1A7O 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
292 1KIR 1 A MONOCLONAL ANTIBODY D1.3 10090
293 1KIR 2 B MONOCLONAL ANTIBODY D1.3 10090
294 4B5E 1 A, B PS2-8 9844
295 2DQE 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
296 2DQE 2 H Ig VH,anti-lysozyme 10090
297 1DVF 1 A FV D1.3 IGG1, KAPPA 10090
298 1DVF 2 B FV D1.3 IGG1, KAPPA 10090
299 1DVF 3 C FV E5.2 IGG1, KAPPA 10090
300 1DVF 4 D FV E5.2 IGG1, KAPPA 10090
301 1G7M 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
302 1G7M 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
303 4X7C 2 C, D Nano-85 Nanobody VHH 30538
304 2Y9R 1 T TITIN M10 DOMAIN, RESIDUES 26828-26926 9606 2.7.11.1 | Details
305 1OAU 1 H, I, J, K IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
306 1OAU 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
307 1B0W 1 A, B, C BENCE-JONES KAPPA I PROTEIN BRE VARIABLE DOMAIN OF LIGHT CHAIN 9606
308 3EBA 1 A CAbHul6 9838
309 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
310 1A6W 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
311 1A6W 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
312 2QTE 1 A, B, C, D Novel immune-type receptor 11 Extracellular fragment 7998
313 1A7R 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
314 1A7R 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
315 4CMM 1 A TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 EXTRACELLULAR DOMAIN, RESIDUES 31-149 9606
316 1WZ1 1 L Ig light chain 10090
317 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
318 3UPA 1 A, B kappa light chain variable domain 9606
319 4I0C 2 C, D cAbHuL5 antibody 9838
320 3LVE 1 A LEN KAPPA-IV LIGHT CHAIN DIMER 9606
321 1A7P 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
322 1A7P 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
323 4K3G 1 A, B immunoglobulin lambda variable domain L5(L89S) 9606
324 2APT 1 A, B T-cell receptor beta chain V 10116
325 1XIW 3 C, G immunoglobulin light chain variable region 10090
326 1XIW 4 D, H immunoglobulin heavy chain variable region 10090
327 5NGV 2 H anti-human ActRIIB mAb BYM338 heavy-chain C-terminal His6-tag VH 9606
328 5NGV 3 L anti-human ActRIIB mAb BYM338 light-chain VL 9606
329 1A7Q 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
330 1A7Q 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
331 5JOE 1 A Titin I81 domain 9606 2.7.11.1 | Details
332 3MC0 1 A, C variable beta 8.2 mouse T cell receptor unp residues 31-144 10090
333 3CAF 1 A Fibroblast growth factor receptor 2 Ig-like C2-type 2 9606 2.7.10.1 | Details
334 5BOP 1 A, C Nanobody 9844
335 4DKA 1 A, B single domain antibody VHH 9844
336 5O05 1 C, D Nanobody (VHH) Nano-42 30538
337 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
338 1DSF 1 L ANTICANCER ANTIBODY B1 FV 10090
339 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
340 3DUU 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
341 3DUU 2 B, D Ig-like protein 10090
342 3BJ9 1 1 Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1 Fusion protein consists of Ig domain of VPREB protein and J-fragment of Ig lambda-5 9606
343 1H5B 1 A MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
344 1H5B 2 B, D MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
345 1H5B 3 C MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
346 3LRG 1 A, B anti-huntingtin VL domain anti-huntingtin VL domain 9606
347 3K74 2 B Nanobody 9844
348 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
349 1KIP 1 A MONOCLONAL ANTIBODY D1.3 10090
350 1KIP 2 B MONOCLONAL ANTIBODY D1.3 10090
351 5LVE 1 A BENCE-JONES PROTEIN LEN G KAPPA CHAIN V-IV, VARIABLE DOMAIN, LIGHT CHAIN 9606
352 2EIZ 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
353 2EIZ 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
354 4QEG 1 A Titin domain I10 9606 2.7.11.1 | Details
355 1SJV 1 A r9 llama VHH single domain antibody 9844
356 1PW3 1 A, B immunoglobulin lambda chain variable region 9606
357 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
358 2QQQ 1 A, B, C, D Novel immune-type receptor 11 Extracellular domain 7998
359 5JPJ 1 A, B 6aJL2 protein 9606
360 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
361 2UZI 2 L ANTI-RAS FV LIGHT CHAIN 9606
362 2APW 1 A T cell receptor beta chain V 10116
363 2I27 1 N, O New Antigen Receptor Ancestral variable domain 7801
364 3T0X 1 A, B Immunoglobulin variable lambda domain M8VLA4(S55P) 9606
365 1UA6 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
366 1UA6 2 H Ig VH,anti-lysozyme 10090
367 1IC7 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
368 1IC7 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
369 4W68 1 A, B Single domain antibody 9844
370 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
371 1CFV 1 L MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
372 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
373 3EAK 1 A, B NbBCII10-FGLA 9838
374 4KJY 2 B, D High-affinity SIRPa variant FD6 9606
375 3Q5O 1 A, B Titin domain M10 (UNP RESIDUES 34253-34350) 9606 2.7.11.1 | Details
376 1QP1 1 A, B, C BENCE-JONES KAPPA I ANTIBODY BRE (LIGHT CHAIN) IMMUNOGLOBULIN FRAGMENT, VARIABLE DOMAIN 9606
377 3U7A 1 A Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain 9606
378 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
379 4ORZ 3 C single domain antibody sdAb19 9844
380 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
381 4UU9 2 B, L MEDI7814 VARIABLE DOMAIN LIGHT CHAIN 9606
382 3MOQ 1 A, B, C, D New antigen receptor variable domain,P3(40) peptide from Amyloid beta A4 protein,New antigen receptor variable domain CHIMERA OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN (RESIDUES 1-87 AND 102-113 FROM UNP Q6X1E6) INSERTED WITH AMYLOID BETA 18-41 (RESIDUES 689-712 FROM UNP P05067) 168098
383 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
384 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
385 1G7L 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
386 1G7L 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
387 2AQ1 1 A, C, E, G T-cell receptor beta chain V 10090
388 1BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
389 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
390 5C1M 2 B Nanobody 39 9844
391 5F7K 2 C, D Nanobody Nb-ER19 9844
392 5LMJ 1 A, B, C, D nanobody 9844
393 5E1H 2 B F8(JOB10) VHH antibody 30538
394 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
395 2YZ8 1 A Obscurin 32th Ig-like domain 9606
396 1IVL 1 A, B IGG-KAPPA M29B FV (LIGHT CHAIN) 10090
397 4OCM 3 C, F Nb1 9844
398 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
399 1A6U 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
400 1A6U 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
401 4X7E 2 C, D Nano-85 Nanobody 30538
402 5F1O 2 B nanobody MU551 9844
403 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
404 5O03 2 C, D Nanobody (VHH) Nano-32 11983
405 2DQI 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
406 2DQI 2 H Ig VH,anti-lysozyme 10090
407 1BRE 1 A, B, C, D, E, F BENCE-JONES KAPPA I PROTEIN BRE 9606
408 4Y8D 2 C, D nanobody 9844
409 3CX5 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
410 3CX5 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
411 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
412 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
413 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
414 4C58 2 B NANOBODY 9844
415 5B8C 1 A, D, G, J Pembrolizumab light chain variable region (PemVL) 9606
416 5B8C 2 B, E, H, K Pembrolizumab heavy chain variable region (PemVH) 9606
417 3DV6 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
418 3DV6 2 B Ig-like protein 10090
419 1VES 1 A, B New Antigen Receptor variable domain 168098
420 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
421 2EKS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
422 2EKS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
423 3BD5 1 A, B catalytic antibody 10090
424 5VXM 2 B Single-domain antibody 20ipaD 30538
425 4XVJ 2 H antibody heavy chain variable domain 9606
426 4XVJ 3 L antibody light chain variable domain 9606
427 1AC6 1 A, B T-CELL RECEPTOR ALPHA VARIABLE DOMAIN 10090
428 4OF7 1 A, B, C, D Protein SYG-1, isoform b D1, UNP residues 19-129 6239
429 4IDL 1 A Single Domain Antibody VHH A9 9844
430 1JV5 1 A Ig kappa chain precursor V region anti-blood group A Fv 9606
431 1JV5 2 B Ig chain heavy chain precursor V region 9606
432 1FVC 1 A, C IGG1-KAPPA 4D5 FV (LIGHT CHAIN) 9606
433 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
434 3K7U 1 A Antibody 9844
435 4Z0X 1 A Antibody HC26AM light chain variable domain 9606
436 4Z0X 2 B Antibody HC26AM heavy chain variable domain 9606
437 1IC5 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
438 1IC5 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
439 4NBY 2 B, C A20.1 VHH 9844
440 4X7D 2 C, D Nano-85 Nanobody VHH 9844
441 5VAN 2 B Nb914 Nanobody 9844
442 2CD0 1 A, B PROTEIN (BENCE-JONES PROTEIN WIL, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) VARIABLE DOMAIN 9606
443 5F7N 2 C, D Nanobody Nb-ER19 30538
444 5OCL 1 A, C, F, H anti-llama nanobody 30538
445 5OCL 2 B, D, E, G anti-vglut nanobody 9844
446 4LAS 1 H Single heavy chain Variable fragment Heavy chain 10090
447 4LAS 2 L Single light chain Variable fragment Light Chain 10090
448 2A9M 1 L, M fluorescein-scfv light chain 9606
449 2A9M 2 H, I fluorescein-scfv heavy chain 9606
450 2YWZ 1 A new antigen receptor variable domain 168098
451 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
452 1SJX 1 A immunoglobulin VH domain 9844
453 3ZKS 2 D XA4813 9844
454 3BYY 1 A T cell receptor beta chain 8.2 Variable domain 10090
455 1A6V 1 L, M, N B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
456 1A6V 2 H, I, J B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
457 5MY6 2 B Nanobody 2Rs15d 9838
458 3DUS 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
459 3DUS 2 B, D Ig-like protein 10090
460 5NH3 2 H, I anti-human ActRIIB mAb BYM338 Fv heavy-chain 9606
461 5NH3 3 L, M anti-human ActRIIB mAb BYM338 Fv light-chain 9606
462 5M2I 2 G, H, I, J, K, L VHH1 9844
463 2COQ 1 A new antigen receptor variable domain 168098
464 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
465 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
466 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
467 3K1K 2 C, D Enhancer 9838
468 4U7S 1 A, B sdAb A3 9844
469 4U3X 1 A, C Human VH domain antibody 9606
470 4W81 1 A Single Domain Antibody 9844
471 5GRV 1 L homo-specific diabody heavy chain 9606
472 5GRV 2 K homo-specific diabody light chain 9606
473 5JMR 1 A, B camelid VHH fragment 9838
474 4W70 1 A Single Domain Antibody 9844
475 2GSG 1 A, C monoclonal antibody light chain variable domain 10090
476 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
477 2W0L 1 A, B, C, D V1-22 PROTEIN 9606
478 5TBD 1 A, D, E, J Fv fragment (mAb4D1) heavy chain 10090
479 5TBD 2 B, F, G, K Fv fragment (mAb4D1) heavy chain 10090
480 4BFB 2 D, E XA4813 9844
481 5DHV 1 A Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
482 5DHV 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
483 5DHV 3 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
484 4LVE 1 A, B LEN KAPPA-IV LIGHT CHAIN DIMER 9606
485 6BIT 3 G, H Tyrosine-protein phosphatase non-receptor type substrate 1 9606
486 43C9 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
487 43C9 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
488 1NMB 2 L FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
489 1NMB 3 H FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
490 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
491 1I8I 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
492 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
493 1OAR 1 H, I, J, K IMMUNOGLOBULIN E FV, RESIDUES 1-122 10090
494 1OAR 2 L, M, N, O IMMUNOGLOBULING E FV, RESIDUES 1-110 10090
495 1D9K 1 A, E T-CELL RECEPTOR D10 (ALPHA CHAIN) 10090
496 1D9K 2 B, F T-CELL RECEPTOR D10 (BETA CHAIN) 10090
497 4LHQ 2 B, D Camelid nanobody 30538
498 3EUU 1 A, B Fibroblast growth factor receptor 2 UNP residues 150-249 9606 2.7.10.1 | Details
499 3DV4 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
500 3DV4 2 B Ig-like protein 10090
501 4OFI 1 A, B, C, D, E, F, G, H Kin of irre, isoform A D1, UNP residues 81-185 7227
502 3ZKX 2 B XA4813 9844
503 3ZKX 3 C XA4815 9844
504 3DAR 1 A, B Fibroblast growth factor receptor 2 D2 domain, Ig-like C2-type 2, UNP residues 146-249 9606 2.7.10.1 | Details
505 5F1K 2 C, D nanobody MU1053 9844
506 3ZLQ 2 C, D XA4813 9844
507 1I3G 1 L ANTIBODY FV FRAGMENT VL DOMAIN 10090
508 1I3G 2 H ANTIBODY FV FRAGMENT VH DOMAIN 10090
509 2WWM 1 C, O OBSCURIN-LIKE PROTEIN 1 RESIDUES 1-106 9606
510 2WWM 2 D, T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
511 3RBG 1 A, B, C, D Cytotoxic and regulatory T-cell molecule 9606
512 1DL7 1 L PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN)) COMBINED LIGHT AND HEAVY CHAIN VIA (G4S)3 LINKER FV (SINGLE CHAIN) 10090
513 1DL7 2 H PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN)) FV (SINGLE CHAIN) 10090
514 4NC0 2 B A26.8 VHH 9844
515 1OCW 1 H IMMUNOGLOBULIN E FV REGION, RESIDUES 1-121 10090
516 1OCW 2 L IMMUNOGLOBULIN E FV REGION, RESIDUES 1-120 10090
517 1IGM 1 L IGM-KAPPA POT FV (LIGHT CHAIN) 9606
518 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
519 5GS1 1 A, M, O, Q light chain 9606
520 5GS1 2 B, N, P, R heavy chain 9606
521 5F7Y 3 C, D Nanobody Nb-ER19 9844
522 2DQG 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
523 2DQG 2 H Ig VH,anti-lysozyme 10090
524 5IMO 1 B Nanobody 9835
525 5U65 1 A, B VHH-5 9838
526 2PXY 1 A T cell receptor alpha chain 10090
527 2PXY 2 B T cell receptor beta chain 10090
528 3BDX 1 A, B, C Amyloid lambda 6 light chain variable region PIP (fragment) Residues 1-111 9606
529 4TYU 1 A, B Single Domain Antibody 9844
530 43CA 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
531 43CA 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
532 2DQH 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
533 2DQH 2 H Ig VH,anti-lysozyme 10090
534 4AQ1 2 B, D NBKB6 VHH 9844
535 6FV0 2 F nanobody 9844
536 2Q1E 1 A, B, C, D Amyloidogenic immunoglobulin light chain protein AL-09 9606
537 2AQ3 1 A, C, E, G T-cell receptor beta chain V 10090
538 4EIG 2 B CA1698 camel antibody fragment 9844
539 3EHB 3 C FV fragment Chain H 10090
540 3EHB 4 D FV fragment Chain L 10090
541 3HB3 3 C ANTIBODY FV FRAGMENT 10090
542 3HB3 4 D ANTIBODY FV FRAGMENT 10090
543 4FFY 1 L DENV1-E111 single chain variable fragment (light chain) 10090
544 4FFY 2 H DENV1-E111 single chain variable fragment (heavy chain) 10090
545 2QJD 1 A, B Novel immune-type receptor 10 Extracellular fragment 7998
546 4N1E 1 A, B, C, D, E, F, G, H immunoglobulin variable light chain domain 9606
547 2X89 1 A, B, C ANTIBODY 9838
548 4WV1 1 C, F Fibroblast growth factor receptor 2 UNP residues 153-251 9606 2.7.10.1 | Details
549 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
550 3BZD 1 A T cell receptor beta chain 8.2 Variable domain 10090
551 5O04 2 E, F Nanobody (VHH) Nano-26 30538
552 5O04 3 C, D Nanobody (VHH) Nano-85 30538
553 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
554 5LBS 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 SCFV fragment, light chain 9606
555 3P9W 2 B, D, F, H human VEGF 9606
556 1AP2 1 A, C MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
557 1AP2 2 B, D MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
558 5F8R 2 C, D Nanobody Nb-ER19 9844
559 1IC4 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
560 1IC4 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
561 4OCL 3 C, F Nb1 9844
562 3CDY 1 A, B IMMUNOGLOBULIN LIGHT CHAIN 9606
563 4RAV 1 B, D Single-chain Fv, VL 9606
564 4RAV 2 A, C single-chain Fv, VH 9606
565 5LWY 2 H V REGION HEAVY CHAIN 10090
566 5LWY 3 L V REGION LIGHT CHAIN 10090
567 1KB9 10 J HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
568 1KB9 11 K LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
569 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
570 4X4X 2 B, D Human Variable Light Chain of Herceptin 9606
571 2Z8V 2 C, D New antigen receptor variable domain 168098
572 4IOS 2 D, E, F, G Llama nanobody 11 9844
573 2W0K 1 A, B V1-22 PROTEIN 9606
574 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
575 2BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
576 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
577 2IBZ 10 X Variable Heavy chain of antibody fragment 10090
578 2IBZ 11 Y Variable Light chain of antibody fragment 10090
579 4K3H 1 A, B, C, D, E, F, G, H Immunoglobulin lambda variable domain L5(L89S) 9606
580 4C57 2 C, D NANOBODY 9844
581 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
582 2Z8W 2 C, D New antigen receptor variable domain 168098
583 4OCN 3 C, F Nb1 9844
584 4GRW 3 E, G Nanobody 124C4 9844
585 4GRW 4 F, J Nanobody 37D5 9844
586 4GRW 5 H, I Nanobody 22E11 9844
587 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
588 3BYT 1 A, C, E, G T cell receptor beta chain 8.2 10090
589 4NC2 2 B B39 VHH 9844
590 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
591 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
592 2OI9 2 B T cell receptor alpha chain 10090
593 2OI9 3 C T cell receptor beta chain 10090
594 4HGM 1 A Shark V-NAR 7797
595 3BD4 1 A, B catalytic antibody 10090
596 1WT5 1 A, B ANTI EGFR ANTIBODY FV REGION VH fragment 9606
597 1WT5 2 C, D ANTI EGFR ANTIBODY FV REGION VL fragment 9606
598 6EY0 2 E, G, H llama nanobody nb01 9844
599 6EY0 3 F llama nanobody nb01 9844
600 1JHL 1 L IGG1-KAPPA D11.15 FV (LIGHT CHAIN) 10090
601 1JHL 2 H IGG1-KAPPA D11.15 FV (HEAVY CHAIN) 10090
602 5F9A 2 C Nanobody Nb-ER19 9844
603 2IJ0 2 C, E penultimate affinity-matured variant of hVbeta 2.1, D10 9606
604 4LLV 1 A, C, E, H 4E10 Fv heavy chain 9606
605 4LLV 2 B, D, F, L 4E10 Fv light chain 9606
606 4LAR 1 H Single heavy chain variable fragment Heavy Chain 10090
607 4LAR 2 L Single light chain variable fragment Light Chain 10090
608 5CBA 1 A, C 3b4 heavy chain 9606
609 5CBA 2 B, D 3b4 light chain 9606
610 5VXJ 2 B, D, F, H, J single-domain antibody JMK-E3 30538
611 1A14 2 H NC10 FV (HEAVY CHAIN) VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
612 1A14 3 L NC10 FV (LIGHT CHAIN) VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
613 1C08 1 A ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VL FRAGMENT 10090
614 1C08 2 B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VH FRAGMENT 10090
615 2OTW 1 A, C Fv light chain avriable domain VL 10090
616 2OTW 2 B, D Fv heavy chain variable domain VH 10090
617 3CU1 1 A, C Fibroblast growth factor receptor 2 Ig-like C2-type 2 domain, UNP residues 150-249 9606 2.7.10.1 | Details
618 3STB 1 A, B single domain antibody VHH 9844
619 2YSS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
620 2YSS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
621 4W6W 2 B NbFedF6 9844
622 5JA8 2 B, D, F, H Nanobody 2 9844
623 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
624 2YBR 2 B, E, H SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN, RESIDUES 118-263 9606
625 2JJT 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
626 2I26 1 N, O, P New Antigen Receptor Ancestral variable domain 7801
627 2BJM 1 H IGE SPE7 HEAVY CHAIN ANTHRONE ATTACHED HEAVY CHAIN, RESIDUES 1-120 10090
628 2BJM 2 L IGE SPE7 LIGHT CHAIN LIGHT CHAIN, RESIDUES 1-110 10090
629 1P4B 1 L Antibody Variable light chain 10090
630 1P4B 2 H Antibody Variable heavy chain 10090
631 5U4M 2 B V1C7 VHH antibody 30538
632 5O0W 2 E, F, G, H Nb474 30538
633 4Y5V 1 A, D, G diabody 305 VH domain 9606
634 4Y5V 2 B, E, H Diabody 305 VL domain 9606
635 1I9E 1 A CYTOTOXIC TCELL VALPHA DOMAIN N-TERMINAL DOMAIN OF ALPHA CHAIN 10090
636 1DQL 1 L IGM MEZ IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN FRAGMENT 9606
637 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
638 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
639 3V0A 3 C Llama antibody F12 9844
640 2Z35 1 A T-cell receptor alpha-chain 10090
641 2Z35 2 B T-cell receptor beta-chain 10090
642 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
643 3K80 1 A, B Antibody 9844
644 5VAQ 2 B Nb914 Nanobody 9844
645 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
646 5F8Q 2 C, D Nanobody Nb-ER19 9844
647 4U05 1 A, B Single Domain Antibody 9844
648 5F9D 2 C Nanobody Nb-ER19 9844
649 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
650 4X4Y 2 B, D Human Variable Light Chain of Herceptin 9606
651 4LGP 2 B, D VHH1 camelid nanobody 30538
652 2P48 2 B ANTIBODY CAB-RN05 9838
653 5U4L 2 B V1C7 VHH antibody G29R variant 30538
654 5VXK 1 B single-domain antibody JMK-H2 30538
655 5F7M 2 C, D Nanobody Nb-ER19 9844
656 3MFG 2 B V_segment translation product 9606
657 1VER 1 A New Antigen Receptor variable domain 168098
658 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
659 5F7W 2 C, D Nanobody Nb-ER19 9844
660 4YQX 1 H, N JES6-1 VH domain 10116
661 4YQX 2 L, O JES6-1 VL domain 10116
662 1FO0 4 A PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
663 1FO0 5 B PROTEIN (BM3.3 T CELL RECEPTOR BETA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
664 1EZV 10 X HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
665 1EZV 11 Y LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
666 3U6R 1 A, H Antibody 1:7 (Heavy chain) 9606
667 3U6R 2 B, L Antibody 1:7 (Light chain) 9606
668 1U3H 1 A, E T-cell receptor alpha-chain V2.3-J39-C 10090
669 1U3H 2 B, F Mouse TCRVbeta 172.10, extracellular variable domain 10090
670 1KTR 1 L Anti-his tag antibody 3d5 variable light chain 10090
671 1KTR 3 H Anti-his tag antibody 3d5 variable heavy chain 10090
672 2YWY 1 A, B, C, D new antigen receptor variable domain 168098
673 1NMC 2 B, H SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
674 1NMC 3 C, L SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
675 1KB5 1 A KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
676 1KB5 2 B KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
677 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
678 4NC1 2 C, D A20.1 VHH 9844
679 4NC1 3 E, F A26.8 VHH 9844
680 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
681 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
682 2DQF 1 A, D lysozyme binding Ig kappa chain V23-J2 region 10090
683 2DQF 2 B, E Ig VH,anti-lysozyme 10090
684 1B88 1 A, B T CELL RECEPTOR V-ALPHA DOMAIN V-ALPHA DOMAIN 10090
685 5E7F 1 A, B, C nanobody L06 9838
686 2P46 2 B, D ANTIBODY CAB-RN05 9838
687 3CXH 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
688 3CXH 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
689 2E7L 1 A, B Cytotoxic Tcell receptor UNP RESIDUES 21-132 10090
690 2E7L 2 C, D Beta-chain UNP RESIDUES 30-144 10090
691 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
692 3OWE 1 A, C, E, G, I, K, M, O Beta-chain VARIABLE DOMAIN 10090
693 5LHP 2 B Camelid-Derived Antibody Fragment 30538
694 2ICW 5 I, K T-cell receptor alpha chain V residues 21-131 10090
695 2ICW 6 J, L T-cell receptor beta chain V 10090
696 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
697 1P84 10 J Heavy Chain (Vh) Of Fv-Fragment 10090
698 1P84 11 K Light Chain (Vl) Of Fv-Fragment 10090
699 2ATP 3 B, D T-cell surface glycoprotein CD8 beta chain CD8b ectodomain fragment 10090
700 5SV4 1 A, B Single Domain Antibody A3C8 9844
701 4LGS 2 B Camelid nanobody (VHH4) 30538
702 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
703 2XTJ 2 B FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
704 2XTJ 4 D FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131 9606
705 5CBE 1 A, C E10 heavy chain 9606
706 5CBE 2 B, D E10 light chain 9606
707 2P47 2 B ANTIBODY CAB-RN05 9838
708 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
709 3WXW 2 H V region heavy chain 10090
710 3WXW 3 L V region light chain 10090
711 3K3Q 1 A llama Aa1 VHH domain 9844
712 1F6L 1 L ANTI-FERRITIN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE LIGHT CHAIN 9606
713 3LRH 1 A, C, E, G, I, K, M, O anti-huntingtin VL domain anti-huntingtin VL domain 9606
714 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
715 1AR1 3 C ANTIBODY FV FRAGMENT 10090
716 1AR1 4 D ANTIBODY FV FRAGMENT 10090
717 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
718 5VNW 2 C, D Nb.b201 32630
719 1BVK 1 A, D HULYS11 FV 9606
720 1BVK 2 B, E HULYS11 FV 9606
721 6FE4 2 F, G, H, I, J Nb113 30538
722 5FV1 1 L, M VK DOMAIN ANTIBODY VK DOMAIN ANTIBODY, RESIDUES 1-108 9606
723 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
724 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
725 2CJU 2 L NQ16-113.8 ANTI-PHOX ANTIBODY 10090
726 5HVF 2 B VHH-i83 30538
727 1P4I 1 L ANTIBODY VARIABLE LIGHT CHAIN 10090
728 1P4I 2 H antibody variable heavy chain 10090
729 4PGJ 1 A, C Human heavy chain domain antibody 9606
730 2LVE 1 A RLEN KAPPA-IV LIGHT CHAIN DIMER 9606
731 4KDT 1 A, B Nanobody24 9835
732 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
733 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
734 2VH5 2 L ANTI-RAS FV LIGHT CHAIN 9606
735 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
736 4RSV 1 A Obscurin UNP residues 4337-4429 9606 2.7.11.1 | Details
737 5MJE 2 B Nanobody 8 9844
738 3LH2 2 H, I, J, K Fv 4E10 heavy chain 9606
739 3LH2 3 L, M, N, O Fv 4E10 light chain 9606
740 3OGO 2 E, F, G, H GFP-nanobody 9838
741 4C59 2 B NANOBODY 9844
742 5VXL 2 B single-domain antibody JPS-G3 30538
743 1OAZ 2 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
744 1OAZ 3 L, N IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
745 4DK6 1 A, B single domain antibody VHH 9844
746 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
747 1CL7 2 H PROTEIN (IGG1 ANTIBODY 1696 (variable heavy chain)) FAB 10090
748 5F7L 2 B, D Nanobody Nb-ER14 9844
749 1KJ2 4 A, D KB5-C20 T-Cell receptor alpha-chain Fv fragment , variable domain 10090
750 1KJ2 5 B, E KB5-C20 T-Cell receptor beta-chain Fv fragment , variable domain 10090
751 1OAY 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
752 1OAY 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
753 5HVG 2 B, D VHH-a204 30538
754 4LAQ 1 H Single heavy chain variable fragment Heavy chain 10090
755 4LAQ 2 L Single light chain variable fragment Light Chain 10090
756 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
757 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
758 5HVH 2 B VHH-a204 30538
759 5HVH 3 C VHH-i83 30538
760 4XT1 3 C nanobody 7 30538
761 5LXG 2 H V REGION HEAVY CHAIN 10090
762 5LXG 3 L V REGION LIGHT CHAIN 10090
763 5HM1 1 A, B, C lama VHH antibody 2E7 9844
764 5FUC 3 E, V VHH6 9838
765 4RZC 1 A, C, E, H Fv M6P-1 light chain 9986
766 4RZC 2 B, D, F, L Fv M6P-1 heavy chain 9986
767 3H3P 1 H, I Fv 4E10 heavy chain 9606
768 3H3P 2 L, M Fv 4E10 light chain 9606
769 5O2U 2 B, D VHH 59H10 9844
770 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
771 5O5I 1 A Roundabout homolog 1 9606
772 3NN8 1 A, C, D, G Engineered scFv, heavy chain 10090
773 3NN8 2 B, E, F, H Engineered scFv, light chain 10090
774 5OMN 2 C Nanobody (VHH) Nano-27 30538
775 4KRP 2 B Nanobody/VHH domain 9G8 9844
776 1OAX 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
777 1OAX 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
778 4FHB 2 D Nb179 9844
779 4DK3 1 A, B single domain antibody VHH 9844
780 4KRL 1 B Nanobody/VHH domain 7D12 9844
781 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
782 4V1D 2 B SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN 9606
783 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
784 4V1D 5 E SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN 9606
785 2Z31 1 A T-cell receptor alpha-chain 10090
786 2Z31 2 B T-cell receptor beta-chain 10090
787 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
788 1NMA 2 L FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
789 1NMA 3 H FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
790 1NAM 1 A BM3.3 T Cell Receptor alpha-Chain Fv Fragment, Variable Domain 10090
791 1NAM 2 B BM3.3 T Cell Receptor beta-Chain Fv Fragment, Variable Domain 10090
792 3B9K 4 B, F T-cell surface glycoprotein CD8 beta chain Ig-like V-type domain 10090
793 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
794 4LDE 2 B Camelid Antibody Fragment 9844
795 4Y5Y 1 A, D diabody 330 VH domain 9606
796 4Y5Y 2 B, E diabody 330 VL domain 9606
797 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
798 1BVL 1 A, C HULYS11 FV 10090
799 1BVL 2 B, D HULYS11 FV 10090
800 3RJQ 2 B Llama VHH A12 9844
801 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
802 4UNT 1 A, B, C, D, E, F, G, H IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
803 4UOW 1 0, 2, 4, 6, 8, A, C, E, G, I, K, M, O, Q, S, U, W, Y OBSCURIN FIRST IG DOMAIN, RESIDUES 26829-26925 9606
804 4UOW 2 1, 3, 5, 7, 9, B, D, F, H, J, L, N, P, R, T, V, X, Z TITIN M10 DOMAIN, RESIDUES 7-99 9606 2.7.11.1 | Details
805 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
806 3AB0 3 C, F antibody ScFv fragment, light chain 10090
807 3LHP 1 H, I Fv 4E10 heavy chain 9606
808 3LHP 2 L, M Fv 4E10 light chain 9606
809 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
810 2BX5 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O VD9 VKI LIGHT-CHAIN LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
811 6EQI 2 B Nb696 9844
812 2OL3 2 B BM3.3 T-CELL RECEPTOR BETA-CHAIN 10090
813 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
814 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
815 4KFZ 2 C, D Anti-LMO2 VH 9606
816 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
817 2UUD 2 K, L NQ10-1.12 ANTI-PHOX ANTIBODY 10090
818 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
819 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
820 4Y5X 2 B, E, H, K diabody 310 VH domain 9606
821 4YGA 2 B, D, F, H VHH-1B7 30538
822 4UT9 2 H, I, J, K BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, HEAVY CHAIN DOMAIN 9606
823 4UT9 3 L, M, N, O BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, LIGHT CHAIN DOMAIN 9606
824 2A9N 1 L, M fluorescein-scfv light chain 9606
825 2A9N 2 H, I fluorescein-scfv heavy chain 9606
826 5XQY 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 Y96K mutant of REI VL 9606
827 5GS0 2 C, E light chain (anti-TLR3) 10090
828 5GS0 3 D, F heavy chain (anti-TLR3) 10090
829 5GS0 4 H, X heavy chain (anti-Lid) 10090
830 5GS0 5 L, Y light chain (anti-Lid) 10090
831 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
832 1KYO 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT RESIDUES 1-127 10090
833 1KYO 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT RESIDUES 1-107 10090
834 5GRJ 1 H avelumab H chain 9606
835 5GRJ 2 L avelumab L chain 9606
836 4NKD 1 A, C, E, G Engineered scFv heavy chain 10090
837 4NKD 2 B, D, F, H Engineered scFv light chain 10090
838 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
839 5FM5 2 O, P OBSCURIN-LIKE-1 OL3 (THIRD IG DOMAIN), RESIDUES 251-339 9606
840 4KRO 2 B Nanobody/VHH domain EgA1 9844
841 3WXV 2 H V region heavy chain 10090
842 3WXV 3 L V region light chain 10090
843 1AR2 1 A REI VARIABLE REGION, LIGHT CHAIN 9606
844 4KV5 2 E, G, H, J heavy chain GC1009 scFv 9606
845 4KV5 3 F, I, K, L light chain GC1009 scFv 9606
846 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
847 5TJW 2 K NP-specific inhibitory VHH 30538
848 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
849 1QLE 6 L LIGHT CHAIN ANTIBODY FV FRAGMENT 10090
850 4LDL 2 B Camelid Antibody Fragment 9844
851 3E3Q 3 C, D, I, M, R, V, Z, d T-cell receptor alpha chain V region PHDS58 10090
852 3E3Q 4 E, F, J, N, S, W, a, e TCR beta chain 10090
853 5XP1 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 UNP residues 22-117 9606
854 4LDO 2 B Camelid Antibody Fragment 9844
855 3SN6 5 N Camelid antibody VHH fragment 9844
856 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
857 4M8Q 1 A, H GEP1 Fv heavy chain 9606
858 4M8Q 2 B, L GEP1 Fv light chain UNP residues 21-129 9606
859 5NHR 1 B, L Bimagrumab Fv Light-Chain VL domain LIGAND BINDING domain 9606
860 5NHR 2 A, H Bimagrumab Fv heavy-chain VH 9606
861 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
862 5O8F 2 K, O Nanobody Nb25 9844
863 5O8F 3 L, M, N Nanobody Nb25 9844
864 5NQW 2 C, D 026 9844
865 5C3L 4 D Nanobody Nb15 Nanobody 9838
866 5J3H 2 C mAb 83-7 Fab heavy chain 10090
867 5J3H 3 D mAb 83-7 Fab light chain 10090
868 5U8R 2 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
869 5U8R 3 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
870 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
871 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
872 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
873 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
874 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
875 6B73 2 C, D Nanobody 9844
876 4PIR 2 F, G, H, I, J VHH15 9844
877 5XWD 2 H VH chain of 059-152 9606
878 5XWD 3 D VL chain of 059-152 9606
879 4QKX 2 B R9 protein 9844
880 5JQH 2 C, D Nanobody60, Nb60 9844
881 4YBQ 2 C, E antibody Fv fragment light chain 10090
882 4YBQ 3 D, F antibody Fv fragment heavy chain 10090
883 4PD4 10 J Igh protein 10090
884 4PD4 11 K Ig kappa chain V-V region HP 124E1 10090
885 5DA0 2 B Nanobody 9844
886 4R0L 1 A, H Antibody 1C6 Heavy chain 10090
887 4R0L 3 B, L Antibody 1C6 Light chain UNP residues 20-137 10090
888 5U8Q 3 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
889 5U8Q 4 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
890 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
891 4ODX 2 A, H GEP7 Fv heavy chain 9606
892 4ODX 3 B, L GEP7 Fv light chain 9606
893 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
894 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
895 3E2H 3 B T-cell receptor alpha chain V region PHDS58 10090
896 3E2H 4 C M67 TCR beta chain 10090
897 4H1L 4 G, I Ani2.3 TCR A chain 562
898 4H1L 5 H, J Ani2.3 TCR B chain 562
899 1RVF 5 L FAB 17-IA 10090
900 1RVF 6 H FAB 17-IA 10090
901 5JZ7 2 C, G, H, J MEDI578 scFv, heavy chain 9606
902 5JZ7 3 D, I, K, L MEDI578 scFv, light chain 9606
903 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
904 4MQS 2 B Nanobody 9-8 9844
905 5DHY 1 A, H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
906 5DHY 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
907 1QFW 3 L ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN) FV 10090
908 1QFW 4 H ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN) FV 10090
909 1QFW 5 M ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN) FV 10090
910 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
911 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
912 4OGA 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
913 4OGA 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
914 4MQT 2 B Nanobody 9-8 9844
915 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
916 4NKM 1 A, C, E, G Engineered scFv heavy chain 10090
917 4NKM 2 B, D, F, H Engineered scFv light chain 10090
918 3W11 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
919 3W11 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
920 4NKO 1 A, C, E Engineered scFv light chain 10090
921 4NKO 2 B, D, F Engineered scFv heavy chain 10090
922 5EUL 4 V AYC08 30538